CODAGENIX

SII announced that a vaccine candidate for the novel coronavirus, which has killed more than 2,000 people in China since its outbreak in December-end, is expected to progress to human trial phase within the next six months. SII is the world's largest vaccine manufacturer by a number of doses produced and sold globally, with more than 1.5 billion-doses so far.

Serum Institute of India, the world’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis vaccine VPM1002 is effective as a preventive and immunity booster vaccine against Covid-19.